24 results
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
Regulatory Authority to invoke the FDA Application Integrity Policy respecting “Fraud, Untrue Statements of Material Facts, Bribery and Illegal Gratuities
DEFA14A
ELYM
Eliem Therapeutics Inc
11 Apr 24
Additional proxy soliciting materials
8:10am
with the Foreign Corrupt Practices Act, 15 U.S.C. §§ 78dd-1, et seq., the Organization for Economic Cooperation and Development Convention Against Bribery … of Foreign Public Officials in International Business Transactions and legislation implementing such convention, all other international anti-bribery
8-K
EX-2.1
ELYM
Eliem Therapeutics Inc
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
., the Organization for Economic Cooperation and Development Convention Against Bribery of Foreign Public Officials in International Business Transactions … and legislation implementing such convention, all other international anti-bribery conventions and all applicable anti-corruption or bribery Laws in any
8-K
EX-10.4
ELYM
Eliem Therapeutics Inc
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
security of the Company to facilitate the sale or resale of any of the Shares.
4.30 Anti-Bribery and Anti-Money Laundering Laws. Each of the Company … at all times been in compliance with and its participation in the offering will not violate: (A) anti-bribery laws, including but not limited to, any
10-K
zog3l
7 Mar 22
Annual report
4:03pm
10-Q
tjs5d898ql0bpafp
13 Sep 21
Quarterly report
4:01pm
424B4
dxfo5fqi4gb7612mn
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
fycqnfgz
2 Aug 21
IPO registration (amended)
6:08am
S-1
EX-2.3
d5k8zkl5 jbo
16 Jul 21
IPO registration
5:02pm